These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 20493882
21. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. Mor M, Rivara S, Lodola A, Plazzi PV, Tarzia G, Duranti A, Tontini A, Piersanti G, Kathuria S, Piomelli D. J Med Chem; 2004 Oct 07; 47(21):4998-5008. PubMed ID: 15456244 [Abstract] [Full Text] [Related]
26. PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue. Wyffels L, Muccioli GG, Kapanda CN, Labar G, De Bruyne S, De Vos F, Lambert DM. Nucl Med Biol; 2010 Jul 07; 37(5):665-75. PubMed ID: 20610171 [Abstract] [Full Text] [Related]
29. Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase. Mileni M, Garfunkle J, Ezzili C, Cravatt BF, Stevens RC, Boger DL. J Am Chem Soc; 2011 Mar 23; 133(11):4092-100. PubMed ID: 21355555 [Abstract] [Full Text] [Related]
30. Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues. Otrubova K, Brown M, McCormick MS, Han GW, O'Neal ST, Cravatt BF, Stevens RC, Lichtman AH, Boger DL. J Am Chem Soc; 2013 Apr 24; 135(16):6289-99. PubMed ID: 23581831 [Abstract] [Full Text] [Related]
32. Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase. Scott CW, Tian G, Yu XH, Paschetto KA, Wilkins DE, Meury L, Cao CQ, Varnes J, Edwards PD. Eur J Pharmacol; 2011 Sep 30; 667(1-3):74-9. PubMed ID: 21645511 [Abstract] [Full Text] [Related]
33. Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase. Patricelli MP, Cravatt BF. Biochemistry; 2001 May 22; 40(20):6107-15. PubMed ID: 11352748 [Abstract] [Full Text] [Related]
34. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors. Vincent F, Nguyen MT, Emerling DE, Kelly MG, Duncton MA. Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6793-6. PubMed ID: 19850474 [Abstract] [Full Text] [Related]
38. Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling. Lodola A, Capoferri L, Rivara S, Chudyk E, Sirirak J, Dyguda-Kazimierowicz E, Andrzej Sokalski W, Mileni M, Tarzia G, Piomelli D, Mor M, Mulholland AJ. Chem Commun (Camb); 2011 Mar 07; 47(9):2517-9. PubMed ID: 21240393 [Abstract] [Full Text] [Related]